Lung cancer susceptibility: Are we on our way to identifying a high-risk group?

Future Oncology

Volumn 3, Issue 6, 2007, Pages 617-627

  Kiyohara, Chikako ^a   Yoshimasu, Kouichi ^b   Takayama, Koichi ^a   Nakanishi, Yoichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

At risk genotype; DNA repair enzyme; Genetic polymorphism; Meta analysis; Metabolic enzyme; Pooled analysis; Susceptibility

Indexed keywords

ACYLTRANSFERASE; BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; DNA; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN P53; RAS PROTEIN; TUMOR NECROSIS FACTOR; XENOBIOTIC AGENT;

ADDICTION; ANTINEOPLASTIC ACTIVITY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; DETOXIFICATION; DNA DAMAGE; DNA REPAIR; ENVIRONMENTAL FACTOR; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; METABOLIC ACTIVATION; NUTRITIONAL STATUS; PENETRANCE; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT; TUMOR IMMUNITY; XENOBIOTIC METABOLISM;

DNA REPAIR; DNA REPAIR ENZYMES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 38049184533     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.3.6.617     Document Type: Review

References (38)

1. Doll R, Peto R. In: The Causes ofCancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. Oxford University Press. Oxford, USA (1981).
2. Antoniou AC, Pharoah PD, McMullan G et al.: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer 86(1), 76-83 (2002).
3. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94(2), 153-156 (2001).
4. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer incidence in five continents, Vol. VIII (155) L4RC Sci. Publ. Lyon, France (2002).
5. Ezzati M, Lopez AD: Estimates of global mortality attributable to smoking in 2000. Lancet 362(9387), 847-852 (2003).
6. Tredaniel J, Boftetta P, Saracci R, Hirsch A: Non-smoker lung cancer deaths attributable to exposure to spouse's environmental tobacco smoke. Int. J. Epidemiol. 26(5), 939-944 (1997).
7. Vineis P Hoek G, Krzyzanowski M et al.: Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environ. Health 6, 7 (2007).
8. Willett WC: Diet, nutrition and avoidable cancer. Environ. Health Perspect. 103(Suppl. 8), 165-170 (1995).
9. Samet JM, Cohen AJ: Air pollution and lung cancer. In: Air Pollution and Health. Holgate ST, Samet JM, Koren HS, Maynard R (Eds), Academic Press, San Diego, CA, USA 841-864 (1999).
10. National Research Council, Committee on Health Risks of Exposures to Radon. Board on Radiation Effects Research. In: Health Effects of Exposure to Radon (BEIR VI). National Academy Press, Washington, DC, USA (1988).
11. Boffetta P, Nyberg F: Contribution of environmental factors to cancer risk. Br. Med. Bull. 68, 71-94 (2003).
12. Kamataki T: Metabolism of xenobiotics. In: Cytochrome P-450. 2nd Edition. Omura T, Ishimura Y, Fujii-Kuriyama Y (Eds). Kodansha Ltd., Tokyo, Japan, 141-158 (1993).
13. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin. Trials 7(3) 177-188 (1986).
14. Kiyohara C, Yoshimasu K, Shirakawa T, Hopkin JM: Genetic polymorphisms and environmental risk of lung cancer: a review. Rev. Environ. Health 19(1), 15-38 (2004).
15. Vineis P, Veglia. F, Benhamou S et al.: CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int. J. Cancer 104(5), 650-657 (2003).
16. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y: EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology 17(1), 89-99 (2006).
17. Kiyohara C, Yoshimasu K, Takayarna K, Nakanishi Y: NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet. Med. 7(7), 463-478 (2005).
18. Benhamou S, Lee WJ, Alexandrie AK et al.: Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23(8), 1343-1350 (2002). Erratum in: 23(10), 1771 (2002).
19. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J: Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med. 3(4), E91 (2006).
20. Raimondi S, Paracchini V, Autrup H et al.: Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am. J. Epidemiol. 164(11), 1027-1042 (2006).
21. Borlak J, Reamon-Buettner SM: N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. BMC Med. Genet. 7, 58 (2006).
22. Kiyohara C, Wakai K, Mikami H, Sido K, Ando M, Ohno Y: Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int. J. Cancer 107(1), 139-144 (2003).
23. Miller DP, Asomaning K, Liu G et al.: An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma. Cancer 107(7), 1570-1577 (2006).
24. Taioli E: Biomarkers of genetic susceptibility to cancer: applications to epidemiological studies. Future Oncol. 1(1), 51-56 (2005).
25. Taioli E, Gaspari L, Benhamou S et al.: Polymorphisms ip CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int. J. Epidemiol. 32(1), 60-63 (2003).
26. Zhou W, Thurston SW, Liu G et al.: The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiol. Biomark. Prev. 10(5), 461-466 (2001).
27. Zhou W, Liu G, Thurston SW et al.: Genetic polymorpbisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol. Biomark. Prev. 11(1), 15-21 (2002).
28. Yang Q, Khoury MJ, Sun F, Flanders WD: Case-only design to measure gene-gene interaction. Epidemiology 10(2), 167-170 (1999).
29. Vineis P, Anttila S, Benhamou S et al.: Evidence of gene-gene interactions in lung Carcinogenesis in a large pooled analysis. Carcinogenesis 28(9), 1902-1905 (2007).
30. Kiyohara C, Takayarna K, Nakanishi Y: Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54(3), 267-223 (2006).
31. Kiyohara C, Yoshimasu K: Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int. J. Med. Sci. 4(2), 59-71 (2007).
32. Kiyohara C, Takayama K, Nakanishi Y: DNA repair and lung cancer In: New Research on DNA Repair. Landseer BR (Ed.). Nova Science Publishers Inc., NY, USA 39-84 (2007)
33. Brown KD, Rathi A, Kamath R et al.: The mismatch repair system is required for S-phase checkpoint activation. Nat. Genet. 33(1), 80-84 (2003).
34. Zhou W, Liu G, Miller DP et al.: Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiology Biomark. Prevent. 12(4), 359-365 (2003).
35. Liu G, Zhou W, Park S et al.: The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms. Cancer 101(12), 2802-2808 (2004).
36. Lu X, Zhao W, Huang J et al.: Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case-control study. Hum. Genet. 121(3-4), 327-335 (2007).
37. The International HapMap Consortium: the International HapMap Project. Nature 426(6968), 789-796 (2003).
38. Schwartz AG, Prysak GM, Bock CH, Cote ML: The molecular epidemiology of lung cancer. Carcinogenesis 28(3), 507-518 (2007).